{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":20,"n_cols":5,"rows_kept":20,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[3,2,3,3],[6,2,6,3],[7,2,7,3],[8,2,8,3],[9,2,9,3],[13,2,13,3],[14,2,14,3],[18,2,18,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910454146903321"]
[null,null,"Titolo",null,"Drug discovery and development for Alzheimer's disease 2000 [[electronic resource] /] / Howard M. Fillit, Alan W. O'Connell, editors"]
[null,null,"Pubbl/distr/stampa",null,"New York, : Springer Pub Co., c2002"]
[null,null,"ISBN",null,"1-281-80665-X"]
[{"$nulls":4},"9786611806651"]
[{"$nulls":4},"0-8261-1534-9"]
[null,null,"Descrizione fisica",null,"1 online resource (297 p.)"]
[null,null,"Collana",null,"ISOA Annual Investigators Meeting"]
[null,null,"Disciplina",null,"616.8/31061"]
[null,null,"Soggetti",null,"Alzheimer's disease - Chemotherapy"]
[{"$nulls":4},"Alzheimer's disease - Chemotherapy - Evaluation"]
[{"$nulls":4},"Drugs - Testing"]
[{"$nulls":4},"Electronic books."]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","\"Papers presented at a meeting held at Tarrytown House, NY, on October 29-31, 2000, the first in a planned series entitled, \"Advances in Drug Discovery and Drug Development for Cognitive Aging and Alzheimer's Disease\"-- P. 3-4 of introd."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references and index."]
[null,null,"Nota di contenuto",null,"Contents; Contributors; Acknowledgments; 1 The Challenges of Drug Discovery and Drug Development for Cognitive Aging and Alzheimer's Disease; Part I. Early Detection; Part II. Drug Discovery; Part III. Drug Development-Preclinical; Part IV. Drug Development-Clinical; Index"]
[null,null,null,"Sommario/riassunto","This prestigious volume presents the findings of an international group of academic and biotechnological researchers. Topics range from early detection programs focusing on genetic factors, novel probes for detecting B-amyloid in the living brain, and the use of telephonic screening and MRI's to the diversity of therapeutic areas such as antioxidants, estrogen agonists and various anti-B-amyloid and anti-tangle approaches. The volume is still an indispensable resource for the psychogeriatrician, psychiatrist, clinical investigator, and neurobiologist, and a must for medical libraries."]